Details for 2019740851

Up to date per 01.04.2026

Actions

Title / Product Name

VERWENDUNG DES NEUARTIGEN TYROSINKINASEHEMMERS ANLOTINIB IN OSTEOSARKOM UND CHONDROSARKOM

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2019740851

EP Publication Number

3744325

E-Number

1572833

Language

PCT Number

CN19071846

Publication Date

02.12.2020 A

07.06.2023 B1

Registration Date

07.06.2023

AT Publication Date

15.06.2023

Application Date

16.01.2019

Registration Number

Priorities

22.01.2018

201810058487

IPC

A61K 31/4709 20060101AFI20220530BHEP

Maximum Duration of Protection

16.01.2039

Owner

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.No. 369 Yuzhou South Road Lianyungang, Jiangsu 222062CN

Representative

No representatives present

Inventor

HUA, YingqiNo.100 Haining Rd., Hongkou District Shanghai 200080CN

WANG, GangyangNo.100 Haining Rd., Hongkou District Shanghai 200080CN

CAI, ZhengdongNo.100 Haining Rd., Hongkou District Shanghai 200080CN

WANG, ZhuoyingNo.100 Haining Rd., Hongkou District Shanghai 200080CN

ZHANG, TaoNo.100 Haining Rd., Hongkou District Shanghai 200080CN

WANG, HongshengNo.100 Haining Rd., Hongkou District Shanghai 200080CN

SUN, MengxiongNo.100 Haining Rd., Hongkou District Shanghai 200080CN

WANG, XunqiangNo.369 Yuzhou South Rd. Lianyungang, Jiangsu 222062CN

ZHAN, XiaoleNo.369 Yuzhou South Rd. Lianyungang, Jiangsu 222062CN

YANG, ZhaoqiangNo.369 Yuzhou South Rd. Lianyungang, Jiangsu 222062CN

TU, LifanNo.369 Yuzhou South Rd. Lianyungang, Jiangsu 222062CN

LI, PuNo.369 Yuzhou South Rd. Lianyungang, Jiangsu 222062CN